| Product Code: ETC7624544 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Bacteriophages Therapy Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Ireland Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Ireland Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Ireland Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Ireland Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections in Ireland |
4.2.2 Growing awareness about the benefits of bacteriophages therapy as an alternative to antibiotics |
4.2.3 Rising investments in research and development of bacteriophages therapies |
4.3 Market Restraints |
4.3.1 Regulatory challenges related to the approval and commercialization of bacteriophages therapies |
4.3.2 Limited availability of clinical data supporting the efficacy and safety of bacteriophages therapies in Ireland |
5 Ireland Bacteriophages Therapy Market Trends |
6 Ireland Bacteriophages Therapy Market, By Types |
6.1 Ireland Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Ireland Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Ireland Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Ireland Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Ireland Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Ireland Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Ireland Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Ireland Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Ireland Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Ireland Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Ireland Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Ireland Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Ireland Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Ireland Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Ireland Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Ireland Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Ireland Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Ireland Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Ireland Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Ireland Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Ireland Bacteriophages Therapy Market Export to Major Countries |
7.2 Ireland Bacteriophages Therapy Market Imports from Major Countries |
8 Ireland Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted on bacteriophages therapies in Ireland |
8.2 Adoption rate of bacteriophages therapies by healthcare facilities in Ireland |
8.3 Investment trends in the development of bacteriophages therapies in Ireland |
9 Ireland Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Ireland Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Ireland Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Ireland Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Bacteriophages Therapy Market - Competitive Landscape |
10.1 Ireland Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Ireland Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here